静脉系统接取设备市场（按设备类型、技术、应用和最终用户）—2025-2032 年全球预测

预计到 2032 年，静脉系统接取设备市场将成长至 81.2 亿美元，复合年增长率为 6.70%。

主要市场统计数据
基准年2024年	48.3亿美元
预计2025年	51.3亿美元
预测年份：2032年	81.2亿美元
复合年增长率（%）	6.70%

背景介绍，解释影响血管内通路设备采用和创新的临床、操作和监管驱动因素

静脉系统通路设备是现代临床照护的基石，可为各种治疗和诊断提供持续的血管通路。本分析涵盖的设备涵盖中枢和周边血管通路解决方案，旨在满足从短期復苏到长期输液和家庭治疗等各种临床需求。随着临床方案日益复杂，医疗保健专业人员和采购团队越来越需要兼具安全性、易用性和适应不断变化的照护路径的设备。

本报告首先将这些设备置于更广泛的临床和营运环境中。报告检验了由于人口结构变化、慢性病盛行率上升、门诊治疗范围扩大以及复杂治疗方法转向门诊和家庭治疗，设备使用模式如何改变。监管审查和感染预防重点仍然是产品设计和采购选择的核心驱动因素。因此，製造商专注于材料科学、整合安全性和以工作流程为导向的创新，以减少併发症并简化临床程序。

引言部分从背景介绍到策略重点，阐明了报告的范围和分析架构。它概述了所审查的设备类别和技术分类，描述了所考虑的临床应用，并摘要了用于评估供应商、临床应用障碍以及影响产品生命週期的监管动态的调查方法。

分析临床、技术和供应链融合趋势，重塑医疗环境中的设备设计采用途径和筹资策略

由于临床、技术和经济因素的融合，静脉通路器材领域已进入转型重组期。材料和整合安全技术的进步正从渐进式改进转向平台级增强，这些改进优先考虑封闭式系统完整性、连接器标准化和无针通路，以降低感染风险。这项技术转变与日益重视以使用者为中心的设计相吻合，这降低了操作复杂性，并支援在非急诊医院环境中采用。

同时，临床实践模式也在不断发展。门诊输液治疗的扩展和居家医疗项目的加速推进，为中线和周边插入器械带来了新的需求信号，这些器械需要兼顾治疗时间长度、安全插入和维护便利性。监管机构正在加大对上市后监管和器械可追溯性的关注，鼓励製造商投资于标籤、唯一器械标识和品质体系，以便在必要时快速采取纠正措施。同时，供应链弹性已成为一项策略重点，相关人员正在寻求多元化供应商，并为关键製造流程提供资源，以降低中断风险。

总的来说，这些转变要求公司协调研发、製造和商业模式，以支援跨环境护理、整合安全性和连接性，并提供适合临床医生工作流程和以患者为中心的护理途径的系统。

重点评估不断变化的关税政策如何影响医疗设备采购决策、製造足迹和策略性供应链调整

影响医疗设备供应链的贸易政策和关税动态，正在加剧对筹资策略和成本结构的审查。关税的征收或调整会对原料采购、零件进口和成品定价产生连锁反应，迫使製造商重新评估供应商合约和物流安排。对于静脉通路器械而言，这类器械通常依赖全球采购的聚合物零件、精密製造和灭菌服务，关税负担的增加促使製造奖励重新评估地理布局和供应商关係。

因此，相关人员已参与情境规划，以了解累积成本负担、关税实施时机以及缓解措施，例如本地化生产、筛选合格的替代供应商以及重新设计产品以减少对关税敏感型投入的净利率。过渡期影响包括与供应商重新谈判、逐步增加库存，以及注重供应链可视性，以防止利润率下降，同时维持对临床医生和患者的产品供应。

重要的是，应对主导压力的营运响应并非凭空而来。法规合规性、品质监督和上市时间限制决定了供应链转移的可行性和节奏。因此，许多公司优先考虑一种混合模式，将关键零件的近岸外包与商品化投入的多元化全球采购相结合，同时采用合约和营运对冲来保持连续性并管理财务风险。

全面的细分整合将设备架构、临床应用和最终用户环境连结起来，以确定产品的适用性和商业化优先级

细緻的细分框架清楚地阐明了临床需求、技术和护理环境的交汇点，从而决定了设备的选择和创新重点。根据设备类型，市场分为中心静脉通路和周边静脉通路。中心静脉通路包括植入式装置、非隧道式导管、周边置入的中央静脉导管、隧道式中央静脉导管和带套囊的中央静脉导管，每种导管均针对不同的治疗时间和风险状况进行了优化。週边通路包括中线静脉导管和周边静脉导管，用于短期至中期治疗，并越来越多地用于门诊和家庭环境中，在这些环境中，易于插入和维护至关重要。

从技术角度来看，设备可分为封闭式、整合式和开放式系统。封闭式系统强调透过封闭路径预防感染；整合式系统将多种功能元素（例如安全性和存取控制）整合到统一的平台中；开放式系统则优先考虑模组化和相容性。这些技术差异决定了采购选择，取决于临床优先顺序、互通性要求和员工培训考虑。

应用维度涵盖临床用例（例如输血、诊断检测、药物管理以及液体和营养支援）如何影响设备规格。每种应用对流量、相容性和停留时间的要求各不相同，从而为产品选择和通讯协定提供参考。最后，终端使用者细分区分门诊手术中心、居家医疗、长期照护机构以及医院和诊所，并认识到设备功能和包装必须与每种护理环境的功能和工作流程一致。这些细分视角为评估产品适用性、开发优先顺序和商业化策略提供了实用的架构。

区域分析比较了美洲、欧洲、中东和非洲以及亚太地区的采购动态、监管重点和临床采用模式

区域动态对各市场的临床应用、监管途径及商业策略有重大影响。在美洲，医疗保健提供者需要管理复杂的私人和公共付款人组合、大量的手术以及强大的门诊护理基础设施，这推动了对性能可靠、工作流程简化且符合严格安全标准的设备的需求。该地区的买家通常优先考虑那些具有明确临床价值和营运效率、并拥有强大的报销途径和成熟分销网络的产品。

在欧洲、中东和非洲，监管机构优先考虑统一安全标准，而由于采购策略和预算限制，医疗保健系统差异巨大。该地区的相关人员越来越多地采用能够降低併发症发生率和整体医疗保健成本的技术，同时兼顾可负担性和合规性。此外，私营部门的成长和公共卫生领域的投资正在创造基于品质和上市后支援的产品差异化机会。

在亚太地区，医疗基础设施的快速现代化、门诊和居家医疗服务覆盖范围的扩大以及国内製造业的雄心壮志正在塑造一个充满活力的竞争格局。寻求进入该地区的製造商优先考虑可扩展的生产模式、监管参与以及适应当地的临床实践和采购机制。综合起来，这些区域模式要求製造商根据每个地区的临床重点和营运现状，客製化其上市方案、监管策略和供应链布局。

评估竞争性创新路径和策略伙伴关係将决定市场领导地位和长期产品可行性

静脉通路器械市场的竞争动态体现在差异化产品组合、策略伙伴关係以及技术和製造方面的定向投资。领先公司通常会在核心产品线与相关创新之间取得平衡，例如整合固定係统、抗菌材料以及旨在提升相容性并降低操作复杂性的连接器标准化概念。为了满足临床医生的偏好和报销压力，各公司也在扩展服务，以支援培训、应用和远端监控，从而降低併发症率并展示实际应用效果。

合併和策略联盟仍然是获取材料科学、灭菌技术和封闭式系统工程领域能力的常见途径。同时，规模较小的专业化公司通常专注于利基临床问题或平台创新，而大型製造商则会选择性地收购或授权这些技术。由于从研发到规模化的转变需要强大的品质系统和监管敏锐度，许多公司正在投资本地製造和监管能力，以加快核准和本地市场准入。

供应链的韧性和成本管理也将决定竞争定位。拥有多元化、品质有保证的供应基础并投资于裁员的公司，将在市场波动期间享有更大的灵活性。最终，市场领导地位将属于那些将临床证据生成、以用户为中心的设计、可扩展的生产以及与多种环境下医疗服务趋势相符的商业模式相结合的公司。

为製造商和医疗系统提供一系列切实可行的策略行动，以提高创新供应链的弹性，并将证据产生与商业性执行结合起来，以实现有意义的采用

产业领导者应推行协调一致的议程，将产品创新与营运韧性和已证实的临床价值结合。首先，优先考虑能够降低感染风险和操作复杂性的设计，透过整合封闭式系统功能和锁定机制，同时确保与常见连接器和输液标准的兼容性。其次，制定平衡成本效益和供应链韧性的生产策略。实现零件采购多元化，选择合格的区域生产合作伙伴，并建立紧急库存，以在供应中断期间保持临床供应的连续性。

第三，投资于产生证据，证明其在医院、门诊手术中心和居家医疗环境中的实际应用效果。过渡性应用通常依赖案例研究和试验计画，这些研究和项目能够证明併发症减少、手术时间缩短或整体医疗成本降低。第四，加强监管和上市后监测能力，以加快核准并快速回应安全讯号。第五，培育商业模式，包括临床医生培训、实施支援和服务提供，以降低非医院环境中的应用门槛。

透过协调实施这些优先事项，公司可以改善产品与市场的契合度，最大限度地降低与贸易和供应中断相关的营运风险，并基于临床影响和营运可靠性创造可持续的竞争优势。

混合方法调查方法，将主要临床医生研究与次要监管和技术审查以及供应链映射相结合。

支撑本分析的研究将结构化的一手资料研究与全面的二手资料研究以及系统级供应链图谱相结合，以确保研究的严谨性和适用性。一手资料研究包括对急诊和门诊病人临床医生、采购主管、监管专家和设备工程师的访谈，旨在获取关于设备性能、采用障碍和工作流程整合的实证见解。这些讨论促成了对产品属性和采用驱动因素进行定性优先排序，这些属性和驱动因素在实际应用中至关重要。

二次研究整合了监管指南、临床实践建议、同行评审文献和公开的技术规范，以检验产品分类并了解安全性和性能预期。供应链分析绘製了聚合物导管、连接器和灭菌服务的典型组件流程图，突显了融合点和潜在瓶颈。调查方法包括交叉检验一手资料和二手资料、对访谈结果进行主题编码以及对技术和监管趋势进行三角测量。

为确保可信度，调查团队记录了各种假设，考虑了替代政策和贸易转变情景，并对营运影响进行了敏感性检验。最终得出了一套切实可行、以行动为导向的综合方案，将临床重点与产品特性以及製造商和医疗保健系统的战略需求紧密结合。

综合结果和简明结论强调了临床重点、监管准备和供应链弹性是血管通路设备策略成功的支柱

最后，血管通路器械对于现代医疗服务依然至关重要，其发展也反映了向门诊护理、感染预防和弹性供应链的广泛转变。如今，临床需求优先考虑安全、易用且适用于所有医疗环境的器械，而製造商则面临着对循证医学、法规遵从性和业务连续性的日益增长的期望。因此，将产品创新与实际临床工作流程和采购现实相结合是成功的关键。

展望未来，投资于整合安全能力、区域製造灵活性和可靠上市后证据的相关人员将最有能力满足临床医生的需求，并应对复杂的监管和贸易环境。此外，伙伴关係将抓住最持久的机会。

整体而言，这个市场提出了重要的策略选择：透过专注于临床影响、供应链弹性和严谨的证据生成，公司可以创造永续的竞争优势，同时为患者照护带来有意义的改善。

目录

第一章 引言

第二章分析方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

• 越来越多地采用无针静脉输液系统，以减少针刺伤并简化工作流程
• 开发具有即时数据分析功能的整合输液泵，实现更智慧的静脉输液治疗管理
• 增加抗菌涂层静脉导管的使用，以降低加加护病房的感染风险
• 人们对封闭式静脉导管系统的兴趣日益浓厚，以最大限度地减少肿瘤治疗期间的污染
• 为加护治疗病患提供血流动力学监测的扩展静脉通路装置
• 随着永续性措施的推进，对环保型一次性静脉输液组件的需求激增
• 整合支援 RFID 的 IV 管连接器，以增强可追溯性和病患安全通讯协定。
• 采用超音波导引週边静脉通路套件提高首次尝试成功率
• 不断发展的数位健康平台，整合静脉输液设备的使用和电子健康记录

第六章：美国关税的累积影响（2025年）

第七章：人工智慧（AI）的累积影响（2025年）

8. 静脉系统接取设备市场（依设备类型）

• 中心静脉通路
  • 植入式装置
  • 非隧道导管
  • 周边置入中央静脉导管
  • 隧道式附袖套中央静脉导管
• 週边静脉通路
  • 中线导管
  • PIV导管

9. 静脉系统接取设备市场（依技术）

• 封闭系统
• 整合系统
• 开放系统

第 10 章静脉系统接取设备市场（依应用）

• 输血
• 诊断测试
• 药物管理
• 补水和营养

第 11 章静脉系统接取设备市场（依最终用户）

• 门诊手术中心
• 居家医疗、长期照护机构
• 医院和诊所

12. 静脉系统接取设备市场（依地区）

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第 13 章静脉系统接取设备市场（依类别）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

14. 静脉系统接取设备市场（依国家）

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十五章竞争格局

• 市占率分析（2024年）
• FPNV定位矩阵（2024年）
• 竞争分析
  • Access Vascular, Inc.
  • Angiplast Private Limited
  • Argon Medical Devices, Inc.
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Delta Med SpA
  • Disposafe Health and Life Care Ltd.
  • FAS United Medical Company
  • Fresenius SE & Co. KGaA
  • Hangzhou Fushan Medical Appliances Co., LTD.
  • Harsoria Healthcare Pvt Ltd
  • IV Access Technology, Inc.
  • ICU Medical, Inc. by Otsuka Holdings Co. Ltd.
  • Kimal PLC
  • Medilivescare Manufacturing Private Limited
  • Medivac Surgical Pvt. Ltd.
  • Medtronic PLC
  • Narang Medical Limited
  • Ningbo GreatCare Trading Co., Ltd.
  • Nipro Corporation
  • Poly Medicure Limited
  • Teleflex Incorporated
  • Terumo Corporation
  • Vygon SAS

The Intravenous System Access Devices Market is projected to grow by USD 8.12 billion at a CAGR of 6.70% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 4.83 billion
Estimated Year [2025]	USD 5.13 billion
Forecast Year [2032]	USD 8.12 billion
CAGR (%)	6.70%

A contextual introduction that explains the clinical, operational, and regulatory drivers shaping adoption and innovation in vascular access devices

Intravenous system access devices constitute a foundational element of contemporary clinical care, enabling sustained vascular access for a broad spectrum of therapies and diagnostics. The devices covered in this analysis span central and peripheral vascular access solutions designed to meet diverse clinical requirements, from short-term resuscitation to long-term infusion and home-based therapies. As clinical protocols have grown more sophisticated, practitioners and procurement teams increasingly demand devices that combine safety features, ease of use, and compatibility with evolving care pathways.

This report opens by situating these devices within the broader clinical and operational context. It examines how demographic shifts, rising chronic disease prevalence, expanded outpatient care, and the migration of complex therapies to ambulatory and home settings have altered device utilization patterns. Regulatory scrutiny and infection prevention priorities remain central drivers of product design and procurement choices. Consequently, manufacturers have concentrated on materials science, integrated safety, and workflow-oriented innovations to reduce complications and streamline clinical procedures.

Transitioning from context to strategic priorities, the introduction clarifies the report's scope and analytical framework. It outlines the device categories and technological classifications under review, explains the clinical applications considered, and summarizes the methodological approach used to evaluate suppliers, clinical adoption barriers, and regulatory dynamics that shape product lifecycles.

An analysis of converging clinical, technological, and supply chain trends that are reshaping device design adoption pathways and procurement strategies across care settings

The intravenous access device landscape has entered a period of transformative realignment driven by converging clinical, technological, and economic forces. Advances in materials and integrated safety technologies have moved beyond incremental improvements toward platform-level enhancements that prioritize closed-system integrity, connector standardization, and needleless access to reduce infection risk. These technological shifts coincide with a growing emphasis on user-centered design that lowers procedure complexity and supports adoption across settings beyond the acute hospital.

Meanwhile, clinical practice patterns are evolving. The expansion of outpatient infusion therapies and the acceleration of home healthcare programs have created new demand signals for midline and peripherally inserted devices that balance duration of therapy with insertion safety and ease of maintenance. Regulatory agencies have increased focus on post-market surveillance and device traceability, prompting manufacturers to invest in labeling, unique device identification, and quality systems that facilitate rapid corrective action when needed. In parallel, supply chain resilience has become a strategic priority; stakeholders are diversifying suppliers and reshoring critical manufacturing steps to mitigate disruption risk.

Taken together, these shifts demand that companies align R&D, manufacturing, and commercial models to support cross-setting care, integrate safety and connectivity features, and deliver systems that fit both clinician workflows and patient-centered care pathways.

A focused evaluation of how evolving tariff policies are influencing sourcing decisions manufacturing footprints and strategic supply chain adjustments for medical devices

Trade policy and tariff dynamics affecting medical device supply chains have intensified scrutiny of sourcing strategies and cost structures. When tariff measures are applied or adjusted, they transmit through raw material procurement, component imports, and finished device pricing, prompting manufacturers to reassess vendor contracts and logistics arrangements. For intravenous access devices, which often rely on polymer components, precision manufacturing, and sterilization services sourced globally, any incremental tariff burden increases the incentive to re-evaluate geographic footprints and supplier relationships.

Consequently, stakeholders have undertaken scenario planning to understand cumulative cost exposure, timing of tariff implementation, and mitigation pathways such as localizing production, qualifying alternative suppliers, or redesigning products to reduce dependence on tariff-sensitive inputs. Transitional impacts include renegotiated supplier contracts, phased inventory adjustments, and greater emphasis on supply chain visibility to prevent margin erosion while preserving product availability for clinicians and patients.

Importantly, the operational response to tariff-driven pressure does not occur in isolation. Regulatory compliance, quality oversight, and time-to-market constraints shape the feasibility and pace of supply chain shifts. As a result, many firms prioritize a hybrid approach that combines nearshoring for critical components with diversified global sourcing for commoditized inputs, while employing contractual and operational hedges to maintain continuity and manage financial exposure.

A comprehensive segmentation synthesis linking device architectures technologies clinical applications and end-user contexts to illuminate product fit and commercialization priorities

A nuanced segmentation framework clarifies where clinical need, technology, and care setting intersect to shape device selection and innovation priorities. By device type, markets separate into central intravenous access and peripheral intravenous access categories. Central options encompass implantable devices, non-tunneled catheters, peripherally inserted central catheters, and tunneled and cuffed central catheters, each optimized for differing duration of therapy and risk profiles. Peripheral access includes midline catheters and peripheral intravenous catheters, which address short- to intermediate-duration therapies and are increasingly used in ambulatory and home settings where ease of insertion and maintenance are critical.

From a technology standpoint, devices cluster into closed systems, integrated systems, and open systems. Closed systems emphasize infection prevention through sealed pathways, integrated systems combine multiple functional elements such as securement and access management into unified platforms, and open systems prioritize modularity and interchangeability. These technological distinctions drive procurement choices depending on clinical priorities, interoperability requirements, and staff training considerations.

The application dimension captures how clinical use cases influence device specification, covering blood transfusion, diagnostic testing, drug administration, and fluid and nutritional support. Each application poses different flow, compatibility, and dwell-time demands that inform product selection and procedural protocols. Finally, end-user segmentation distinguishes ambulatory surgical centers, homecare settings and long-term care facilities, and hospitals and clinics, recognizing that device features and packaging must align with the capabilities and workflows of each care environment. Together, these segmentation lenses provide a practical structure for evaluating product fit, development priorities, and commercialization strategies.

A regional analysis that contrasts procurement dynamics regulatory priorities and clinical adoption patterns across the Americas Europe Middle East Africa and Asia-Pacific

Regional dynamics materially influence clinical adoption, regulatory pathways, and commercial strategies across the market. In the Americas, healthcare providers navigate a complex mix of private and public payers, high procedural volumes, and robust outpatient care infrastructure, driving demand for devices that deliver reliable performance, streamlined workflows, and compliance with stringent safety standards. In this region, purchasers often prioritize products that demonstrate clear clinical value and operational efficiencies, supported by strong reimbursement pathways and established distribution networks.

In Europe, the Middle East and Africa, regulators emphasize harmonized safety standards, while health systems vary widely in procurement sophistication and budgetary constraints. Stakeholders in this region balance affordability with compliance, and they increasingly adopt technologies that demonstrate reduced complication rates and lower total cost of care. In addition, private-sector growth and public health investments create opportunities for product differentiation based on quality and post-market support.

Across Asia-Pacific, rapid modernization of healthcare infrastructure, expanding access to outpatient and homecare services, and domestic manufacturing ambitions shape a dynamic competitive landscape. Manufacturers pursuing this region prioritize scalable production models, regulatory engagement, and adaptations for local clinical practices and procurement mechanisms. Collectively, these regional patterns require manufacturers to customize go-to-market approaches, regulatory strategies, and supply chain footprints to align with each area's clinical priorities and operational realities.

An assessment of competitive positioning innovation pathways and strategic partnerships that determine market leadership and long-term product viability

Competitive dynamics in the intravenous access device market manifest through differentiated portfolios, strategic partnerships, and targeted investments in technology and manufacturing. Leading organizations typically balance core product lines with adjacent innovations such as integrated securement systems, antimicrobial materials, and connector standardization initiatives that facilitate compatibility and reduce procedural complexity. In response to clinician preferences and reimbursement pressures, companies have also extended services that support training, adoption, and remote monitoring to reduce complication rates and demonstrate real-world performance.

Mergers and strategic alliances remain a common pathway for acquiring capability in materials science, sterilization technologies, and closed-system engineering. Concurrently, smaller specialized firms often focus on niche clinical problems or platform innovations that larger manufacturers selectively acquire or license. Transitioning from R&D to scale requires robust quality systems and regulatory acumen, so many companies invest in regional manufacturing and regulatory affairs capabilities to accelerate approvals and local market access.

Supply chain resilience and cost control also shape competitive positioning. Firms that secure diversified, quality-assured supply bases and invest in redundancy enjoy greater flexibility during disruption. Ultimately, market leadership accrues to organizations that combine clinical evidence generation, user-centered design, scalable manufacturing, and commercial models that align with care delivery trends across multiple settings.

A pragmatic set of strategic actions for manufacturers and health systems to align innovation supply chain resilience evidence generation and commercial execution for meaningful adoption

Industry leaders should pursue a coordinated agenda that aligns product innovation with operational resilience and clinical value demonstration. First, prioritize designs that reduce infection risk and procedural complexity by integrating closed-system features and securement mechanisms, while ensuring compatibility with prevailing connector and infusion standards. Second, deploy manufacturing strategies that balance cost efficiency with supply chain resilience; diversify component sourcing, qualify regional production partners, and develop contingency inventories to sustain clinical supply continuity during disruptions.

Third, invest in evidence generation that demonstrates real-world outcomes across hospitals, ambulatory surgical centers, and homecare environments. Transitional adoption often depends on case studies and pilot programs that document reduced complications, shortened procedure times, or lower total care costs. Fourth, strengthen regulatory and post-market surveillance capabilities to accelerate approvals and to respond rapidly to safety signals. Fifth, cultivate commercial models that include clinician training, onboarding support, and service offerings that lower the barrier to adoption in non-hospital settings.

By executing on these priorities in a coordinated manner, companies can improve product-market fit, minimize operational risks associated with trade or supply interruptions, and create durable competitive advantages grounded in clinical impact and operational reliability.

A transparent description of the mixed-methods research approach that integrates primary clinician insights secondary regulatory and technical review and supply chain mapping

The research underpinning this analysis combines structured primary engagements, comprehensive secondary review, and systems-level supply chain mapping to ensure rigor and applicability. Primary research included interviews with clinicians across acute and outpatient settings, procurement leaders, regulatory specialists, and device engineers to capture experiential insights on device performance, adoption barriers, and workflow integration. These discussions informed qualitative prioritization of product attributes and adoption levers that matter in real-world settings.

Secondary research synthesized regulatory guidance, clinical practice recommendations, peer-reviewed literature, and publicly available technical specifications to validate product classifications and to understand safety and performance expectations. Supply chain analysis mapped typical component flows for polymer-based catheters, connectors, and sterilization services, highlighting points of concentration and potential bottlenecks. The methodological approach employed cross-validation between primary and secondary sources, thematic coding of interview responses, and triangulation of technological trends with regulatory trajectories.

To ensure reliability, the research team documented assumptions, reviewed alternative scenarios for policy and trade shifts, and conducted sensitivity checks on operational implications. The result is a defensible, action-oriented synthesis that connects clinical priorities to product attributes and strategic imperatives for manufacturers and health systems.

A concise concluding synthesis that emphasizes clinical priorities regulatory readiness and supply chain resilience as the pillars of strategic success in vascular access devices

In closing, intravenous access devices remain a critical enabler of modern care delivery, and their evolution reflects broader shifts toward outpatient therapies, infection prevention, and resilient supply chains. Clinical demand now prioritizes devices that combine safety, ease of use, and cross-setting applicability, while manufacturers face intensifying expectations for evidence, regulatory compliance, and operational continuity. Consequently, success depends on aligning product innovation with real-world clinical workflows and procurement realities.

Looking ahead, stakeholders who invest in integrated safety features, regional manufacturing flexibility, and robust post-market evidence will be best positioned to meet clinician needs and to navigate regulatory and trade complexities. Moreover, partnerships that accelerate training, streamline adoption, and provide real-world performance data will create tangible differentiation in procurement conversations. As healthcare delivery models continue to decentralize, the firms that translate clinical insight into practical, reliable device systems will capture the most durable opportunities.

Overall, the market presents significant strategic choices; by emphasizing clinical impact, supply chain resilience, and disciplined evidence generation, organizations can deliver meaningful improvements in patient care while building sustainable competitive advantage.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Increasing adoption of needle-free IV access systems to reduce needlestick injury and streamline workflows
• 5.2. Development of integrated infusion pumps with real-time data analytics for smarter IV therapy management
• 5.3. Rise in antimicrobial-coated IV catheters to mitigate infection risks in critical care settings
• 5.4. Growing preference for closed IV catheter systems to minimize contamination during oncology treatments
• 5.5. Introduction of wearable IV infusion devices for ambulatory chemotherapy and patient mobility support
• 5.6. Expansion of IV access devices with hemodynamic monitoring capabilities for intensive care patients
• 5.7. Surge in demand for eco-friendly disposable IV components following sustainability initiatives
• 5.8. Integration of RFID-enabled IV tubing connectors to enhance traceability and patient safety protocols
• 5.9. Adoption of ultrasound-guided peripheral IV access kits to improve first-attempt success rates
• 5.10. Evolution of digital health platforms integrating IV device usage with electronic health records

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intravenous System Access Devices Market, by Device Type

• 8.1. Central Intravenous Access
  • 8.1.1. Implantable Devices
  • 8.1.2. Non-tunneled Catheters
  • 8.1.3. Peripherally Inserted Central Catheter
  • 8.1.4. Tunneled & Cuffed Central Catheter
• 8.2. Peripheral Intravenous Access
  • 8.2.1. Midline Catheter
  • 8.2.2. PIV Catheter

9. Intravenous System Access Devices Market, by Technology

• 9.1. Closed System
• 9.2. Integrated System
• 9.3. Open System

10. Intravenous System Access Devices Market, by Application

• 10.1. Blood Transfusion
• 10.2. Diagnostic Testing
• 10.3. Drug Administration
• 10.4. Fluid & Nutritional Support

11. Intravenous System Access Devices Market, by End User

• 11.1. Ambulatory Surgical Centers
• 11.2. Homecare Settings & Long-term Care Facilities
• 11.3. Hospitals & Clinics

12. Intravenous System Access Devices Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Intravenous System Access Devices Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Intravenous System Access Devices Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Analysis
  • 15.3.1. Access Vascular, Inc.
  • 15.3.2. Angiplast Private Limited
  • 15.3.3. Argon Medical Devices, Inc.
  • 15.3.4. B. Braun SE
  • 15.3.5. Baxter International Inc.
  • 15.3.6. Becton, Dickinson and Company
  • 15.3.7. Delta Med S.p.A.
  • 15.3.8. Disposafe Health and Life Care Ltd.
  • 15.3.9. FAS United Medical Company
  • 15.3.10. Fresenius SE & Co. KGaA
  • 15.3.11. Hangzhou Fushan Medical Appliances Co., LTD.
  • 15.3.12. Harsoria Healthcare Pvt Ltd
  • 15.3.13. I-V Access Technology, Inc.
  • 15.3.14. ICU Medical, Inc. by Otsuka Holdings Co. Ltd.
  • 15.3.15. Kimal PLC
  • 15.3.16. Medilivescare Manufacturing Private Limited
  • 15.3.17. Medivac Surgical Pvt. Ltd.
  • 15.3.18. Medtronic PLC
  • 15.3.19. Narang Medical Limited
  • 15.3.20. Ningbo GreatCare Trading Co., Ltd.
  • 15.3.21. Nipro Corporation
  • 15.3.22. Poly Medicure Limited
  • 15.3.23. Teleflex Incorporated
  • 15.3.24. Terumo Corporation
  • 15.3.25. Vygon SAS

LIST OF FIGURES

• FIGURE 1. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 11. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. BRICS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. G7 INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. NATO INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 28. INTRAVENOUS SYSTEM ACCESS DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY IMPLANTABLE DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY NON-TUNNELED CATHETERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY NON-TUNNELED CATHETERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY NON-TUNNELED CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY NON-TUNNELED CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY NON-TUNNELED CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY NON-TUNNELED CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TUNNELED & CUFFED CENTRAL CATHETER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TUNNELED & CUFFED CENTRAL CATHETER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TUNNELED & CUFFED CENTRAL CATHETER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TUNNELED & CUFFED CENTRAL CATHETER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TUNNELED & CUFFED CENTRAL CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TUNNELED & CUFFED CENTRAL CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY MIDLINE CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PIV CATHETER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PIV CATHETER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PIV CATHETER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PIV CATHETER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PIV CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PIV CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY REGION, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CLOSED SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY REGION, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY INTEGRATED SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY OPEN SYSTEM, BY REGION, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY OPEN SYSTEM, BY REGION, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY OPEN SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY OPEN SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY OPEN SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY OPEN SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY BLOOD TRANSFUSION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY BLOOD TRANSFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC TESTING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC TESTING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DIAGNOSTIC TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DRUG ADMINISTRATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY FLUID & NUTRITIONAL SUPPORT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY FLUID & NUTRITIONAL SUPPORT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY FLUID & NUTRITIONAL SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY FLUID & NUTRITIONAL SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY FLUID & NUTRITIONAL SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY FLUID & NUTRITIONAL SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOMECARE SETTINGS & LONG-TERM CARE FACILITIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOMECARE SETTINGS & LONG-TERM CARE FACILITIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOMECARE SETTINGS & LONG-TERM CARE FACILITIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOMECARE SETTINGS & LONG-TERM CARE FACILITIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOMECARE SETTINGS & LONG-TERM CARE FACILITIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOMECARE SETTINGS & LONG-TERM CARE FACILITIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 127. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 128. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 129. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 130. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 131. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 132. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 133. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 134. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 135. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 136. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 137. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 138. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 139. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 140. AMERICAS INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 141. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 142. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 143. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 144. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 145. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 146. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 147. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 148. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 149. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 150. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 151. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 152. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 153. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 154. NORTH AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 155. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 156. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 157. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 158. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 159. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 160. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 161. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 162. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 163. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 164. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 165. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 166. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 167. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 168. LATIN AMERICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 169. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 170. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 180. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 181. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 182. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 183. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 184. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 185. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 186. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 187. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 188. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 189. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 190. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 191. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 192. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 193. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 194. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 195. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 196. EUROPE INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 197. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 198. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 199. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 200. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 201. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 202. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 203. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 204. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 205. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 206. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 207. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 208. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 209. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 210. MIDDLE EAST INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 211. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 212. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 213. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 214. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 215. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 216. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 217. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 218. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 219. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 220. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 221. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 222. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 223. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 224. AFRICA INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 225. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 226. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 227. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 228. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 229. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 230. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 231. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 232. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 233. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 234. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 235. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 236. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 237. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 238. ASIA-PACIFIC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 239. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 240. GLOBAL INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 241. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 242. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 243. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 244. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 245. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 246. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 247. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 248. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 249. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 250. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 251. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 252. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 253. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 254. ASEAN INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 255. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 256. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 257. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 258. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 259. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 260. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 261. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 262. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 263. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 264. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 265. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 266. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 267. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 268. GCC INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 269. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 270. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 271. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 272. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 273. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 274. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY CENTRAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 275. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2018-2024 (USD MILLION)
• TABLE 276. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY PERIPHERAL INTRAVENOUS ACCESS, 2025-2032 (USD MILLION)
• TABLE 277. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 278. EUROPEAN UNION INTRAVENOUS SYSTEM ACCESS DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 279. EUROPEAN UNION IN